Shingo Nakayamada Selected Research

Shingo Nakayamada Research Topics

Disease

43	Rheumatoid Arthritis 04/2024 - 05/2003
29	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 10/2003
15	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 01/2004
8	Inflammation (Inflammations) 04/2023 - 01/2007
7	Fibrosis (Cirrhosis) 03/2023 - 10/2009
6	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023 - 06/2002
6	Immunoglobulin G4-Related Disease 03/2023 - 08/2018
5	Psoriatic Arthritis 01/2022 - 01/2019
4	Pulmonary Arterial Hypertension 07/2023 - 04/2020
4	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 01/2021
4	Pathologic Processes 01/2022 - 09/2016
4	Systemic Scleroderma (Systemic Sclerosis) 04/2020 - 07/2015
3	Mixed Connective Tissue Disease (MCTD) 07/2023 - 01/2005
3	Infections 07/2023 - 02/2004
3	Lupus Nephritis 01/2023 - 10/2022
3	Arthritis (Polyarthritis) 01/2021 - 02/2004
3	Sjogren's Syndrome (Sjogren Syndrome) 09/2016 - 12/2003
2	Glomerulonephritis 09/2023 - 01/2022
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 09/2023 - 01/2020
2	Osteitis 02/2023 - 10/2022
2	Fever (Fevers) 01/2023 - 01/2020
2	Exanthema (Rash) 01/2023 - 01/2019
2	Synovitis 09/2022 - 05/2003
2	Hypertension (High Blood Pressure) 01/2022 - 04/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
2	Bone Resorption 01/2021 - 06/2005
2	Osteoarthritis 12/2020 - 01/2016
2	Necrosis 12/2020 - 01/2020
2	Bone Fractures (Bone Fracture) 11/2019 - 11/2008
2	Osteoporosis 12/2015 - 06/2005
2	Confusion (Bewilderment) 04/2007 - 10/2004
1	Neoplasms (Cancer) 10/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2023
1	Herpes Zoster 07/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2023
1	Thromboembolism 07/2023
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2023
1	Fibrosarcoma 01/2023
1	Pulmonary Hypertension 01/2023
1	Familial Mediterranean Fever (Periodic Disease) 01/2023

Drug/Important Bio-Agent (IBA)

11	Janus Kinase InhibitorsIBA 07/2023 - 10/2016
10	GlucocorticoidsIBA 07/2023 - 01/2004
9	Immunoglobulin G (IgG)IBA 03/2023 - 08/2018
8	CytokinesIBA 01/2023 - 06/2005
8	AutoantibodiesIBA 12/2021 - 02/2015
6	Antirheumatic Agents (DMARD)IBA 04/2024 - 02/2004
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2005
5	Tumor Necrosis Factor InhibitorsIBA 04/2024 - 01/2018
5	Rituximab (Mabthera)FDA Link 09/2023 - 04/2007
5	AntibodiesIBA 07/2023 - 01/2018
5	Adalimumab (Humira)FDA Link 02/2023 - 02/2015
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2018
5	Abatacept (Orencia)FDA Link 01/2018 - 01/2015
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2010 - 12/2004
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2023 - 01/2020
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 07/2023 - 04/2020
4	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2018
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 02/2004
4	SteroidsIBA 04/2019 - 10/2003
3	Immunosuppressive Agents (Immunosuppressants)IBA 07/2023 - 01/2021
3	InterleukinsIBA 01/2023 - 12/2020
3	tocilizumab (atlizumab)FDA Link 01/2023 - 05/2014
3	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 10/2003
3	mepolizumabIBA 01/2022 - 01/2021
3	belimumabIBA 01/2022 - 01/2019
3	Interleukin-2 (IL2)IBA 12/2021 - 12/2004
3	AntigensIBA 01/2021 - 01/2016
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2007
3	baricitinibIBA 01/2021 - 09/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 06/2005
2	guselkumabIBA 02/2023 - 10/2022
2	AA amyloidosisIBA 01/2023 - 05/2014
2	tofacitinibIBA 01/2023 - 01/2021
2	Antinuclear AntibodiesIBA 01/2022 - 10/2003
2	Interleukin-22 (IL-22)IBA 01/2022 - 01/2018
2	Janus KinasesIBA 01/2021 - 10/2016
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 12/2020 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2005
2	ChromatinIBA 10/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 06/2002
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2014
2	InterferonsIBA 01/2019 - 01/2018
2	mizoribineIBA 10/2009 - 12/2003
2	alfacalcidolIBA 11/2008 - 01/2004
2	IntegrinsIBA 05/2007 - 05/2003
1	anifrolumabIBA 11/2023
1	Homovanillic AcidIBA 10/2023
1	SMN Complex ProteinsIBA 07/2023
1	PyrinIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	canakinumab FDA Link 01/2023

Therapy/Procedure

32	Therapeutics 11/2023 - 10/2003
4	Precision Medicine 04/2023 - 01/2019
3	Remission Induction 01/2023 - 01/2022
1	Molecular Targeted Therapy 12/2023
1	Drug Tapering 03/2023